Cite
HARVARD Citation
Fragkou, P. et al. (2022). Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients. Therapeutic advances in neurological disorders. p. . [Online].